Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04355130
What this trial is testing

Autologous Tansfusion REquirements in Bone MArrow Harvest: The ATREMA Study

Who this might be right for
Bone Marrow Donors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 7
Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Temporarily pausedNCT00073853
What this trial is testing

Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries

Who this might be right for
Spinal Cord Injury
Proneuron Biotechnologies 61
Testing effectiveness (Phase 2)Study completedNCT01528267
What this trial is testing

Bronchoscopic Lung Volume Reduction Using Blood

Who this might be right for
Emphysema
Chelsea and Westminster NHS Foundation Trust 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03229564
What this trial is testing

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

Who this might be right for
Burns
CUTISS AG 12
Not applicableStudy completedNCT02539056
What this trial is testing

The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)

Who this might be right for
OsteoarthritisTraumatic Arthritis
Cellontech Co., Ltd. 22
Post-approval studies (Phase 4)Study completedNCT02872753
What this trial is testing

Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy

Who this might be right for
Meniscectomy
Istituto Ortopedico Rizzoli 90
Large-scale testing (Phase 3)Active Not RecruitingNCT04071457
What this trial is testing

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 1,100
Testing effectiveness (Phase 2)Study completedNCT02362464
What this trial is testing

Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

Who this might be right for
Prostatic NeoplasmsNeoplasms of ProstateProstate Cancer+2 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00514475
What this trial is testing

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Oslo University Hospital 160
Testing effectiveness (Phase 2)Looking for participantsNCT06682130
What this trial is testing

Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma(DLBCL)
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Study completedNCT02292628
What this trial is testing

Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence

Who this might be right for
Faecal Incontinence
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03573700
What this trial is testing

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, Refractory
St. Jude Children's Research Hospital 24
Not applicableStudy completedNCT01314079
What this trial is testing

Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula

Who this might be right for
Crohn's DiseaseFistula
Anterogen Co., Ltd. 37
Testing effectiveness (Phase 2)UnknownNCT01333605
What this trial is testing

IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Fudan University 43
Early research (Phase 1)Looking for participantsNCT06889766
What this trial is testing

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

Who this might be right for
Advanced MelanomaMelanoma MetastaticSarcoma
Centre Hospitalier Universitaire Vaudois 9
Early research (Phase 1)Ended earlyNCT02716805
What this trial is testing

Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Ludwig Institute for Cancer Research 6
Testing effectiveness (Phase 2)Study completedNCT00855400
What this trial is testing

Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 11
Testing effectiveness (Phase 2)Study completedNCT03794167
What this trial is testing

BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Soonchunhyang University Hospital 75
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Next Page